Jeil Pharma Holdings Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	56,189	59,821	37,039	34,760	28,581
Short-Term Investments	17,433	16,062	22,092	18,643	18,643
Trading Asset Securities	5,689	-	-	-	-
Cash & Short-Term Investments	79,312	75,883	59,131	53,403	47,224
Cash Growth	4.52%	28.33%	10.73%	13.08%	57.62%
Accounts Receivable	162,034	188,185	178,437	162,403	149,681
Other Receivables	4,129	13,437	15,743	15,749	15,305
Receivables	166,163	201,621	194,180	178,152	164,986
Inventory	118,839	123,669	125,280	113,266	114,243
Prepaid Expenses	557.25	257.41	370.95	334.14	210.64
Other Current Assets	8,412	8,130	5,565	7,762	8,481
Total Current Assets	373,283	409,561	384,527	352,916	335,144
Property, Plant & Equipment	243,300	243,942	228,862	233,120	212,965
Long-Term Investments	114,148	93,756	87,116	83,167	79,022
Goodwill	-	-	44,862	73,466	151,801
Other Intangible Assets	9,233	5,384	4,532	3,978	3,781
Long-Term Accounts Receivable	-0	-0	-0	-0	-0
Long-Term Deferred Tax Assets	10,138	7,630	5,449	188.47	1,452
Long-Term Deferred Charges	6,583	8,378	8,561	5,494	-
Other Long-Term Assets	119,978	121,784	116,087	113,347	108,256
Total Assets	876,664	890,433	879,997	865,677	892,421
Accounts Payable	99,559	146,189	154,050	162,967	159,388
Accrued Expenses	364.65	379.18	289.4	219.46	144.54
Short-Term Debt	149,487	141,872	195,937	141,247	88,033
Current Portion of Long-Term Debt	240	-	5,800	3,200	6,125
Current Portion of Leases	564.73	672.57	707.58	692.18	806.97
Current Income Taxes Payable	2,156	3,840	774.71	1,160	684.79
Other Current Liabilities	70,697	85,039	55,077	49,019	42,841
Total Current Liabilities	323,069	377,991	412,636	358,505	298,024
Long-Term Debt	16,540	11,900	10,500	16,300	18,531
Long-Term Leases	537.14	767.2	1,198	1,177	1,576
Pension & Post-Retirement Benefits	24,212	16,334	10,679	2,727	3,558
Long-Term Deferred Tax Liabilities	42,369	40,892	37,618	35,755	37,747
Other Long-Term Liabilities	819.71	5,152	5,180	31,421	32,672
Total Liabilities	407,547	453,036	477,811	445,885	392,108
Common Stock	7,987	7,987	7,987	7,987	7,987
Additional Paid-In Capital	201,913	201,825	176,522	176,058	176,384
Retained Earnings	38,267	26,146	79,119	98,245	172,151
Treasury Stock	-3,422	-3,422	-3,422	-3,422	-3,422
Comprehensive Income & Other	73,997	74,414	59,256	58,898	58,631
Total Common Equity	318,741	306,950	319,461	337,765	411,731
Minority Interest	150,376	130,447	82,725	82,028	88,583
Shareholders' Equity	469,117	437,397	402,186	419,792	500,314
Total Liabilities & Equity	876,664	890,433	879,997	865,677	892,421
Total Debt	167,369	155,212	214,143	162,616	115,072
Net Cash (Debt)	-88,058	-79,329	-155,012	-109,213	-67,848
Net Cash Per Share	-5734.02	-5168.22	-10097.73	-7114.36	-4419.76
Filing Date Shares Outstanding	15.37	15.35	15.35	15.35	15.35
Total Common Shares Outstanding	15.37	15.35	15.35	15.35	15.35
Working Capital	50,213	31,570	-28,109	-5,588	37,120
Book Value Per Share	20731.29	19995.26	20810.28	22002.60	26820.87
Tangible Book Value	309,507	301,566	270,066	260,320	256,148
Tangible Book Value Per Share	20130.74	19644.54	17592.61	16957.74	16685.95
Land	120,086	119,324	98,147	98,120	83,677
Buildings	145,461	142,982	140,779	140,778	137,880
Machinery	141,834	135,149	107,539	101,172	84,428
Construction In Progress	6,280	4,923	3,269	3,851	11,778

Source: S&P Global Market Intelligence. Standard template. Financial Sources.